Treatment and Research

Since 2003, New England Cord Blood Bank has safely shipped clients’ cord blood stem cells to transplant facilities around the world for use in transplants, research, or clinical trials. 

Treatments and Research Involvement

  • March 2006: Oxygen deprivation at birth
  • July 2007: Neonatal herpes simplex encephalitis with brain damage
  • July 2008: Cerebral Palsy
  • March 2009: Mild Cerebral Palsy
  • March 2009: Cerebral Palsy
  • June 2009: Cerebral Palsy
  • June 2011: Cerebral Palsy
  • March 2013: Cerebral Palsy
  • January 2017: Autism
  • February 2018: Autism
  • April 2018: Autism
  • April 2019: Autism
  • October 2003: For Hematopoietic reconstitution
  • May 2004: Fanconi Anemia
  • December 2007: ALL – Acute Lymphoblastic Leukemia
  • October 2006: ALL – Acute Lymphoblastic Leukemia
  • July 2007: Fanconi Anemia
  • January 2008: Medullablastoma

Although compared to some of the large cord blood banks our total number of units released for transplant is lower, that number should not be a concern. Our unit release percentage is typical of the other vendors in the industry. We are happy that not many of our clients have needed to access their cells  – it means that their families are healthy! However, rest assured that we have the experience necessary to work with any hospital or transplant facility to prepare and safely transport your cells if they are ever needed. If cells are requested for release, we follow the strictest protocols to ensure safe transportation to the designated medical facility. The key is peace of mind – our deep history and expertise in cryopreservation give our clients the confidence that their cord blood and cord tissue will be safe and ready to use if ever needed.